Stocks to Watch: Wynn Resorts, Estrella Immunopharma, Amazon.com

By Connor Hart

Wynn Resorts' shares received a boost after Morgan Stanley raised its recommendation on the stock, shortly after China's central bank announced a stimulus package. The company, with a large presence in the competitive Chinese market of Macau, should benefit from its continued investments and high-end brand, Morgan Stanley analyst Stephen Grambling said in a research note. Shares edge higher in after-hours trading after ending Friday's regular session up 7.2%, to $97.62.

Estrella Immunopharma said the first patient in a clinical trial had a complete response to a T-cell therapy for lymphoma. The biopharmaceutical company said the patient, diagnosed with follicular lymphoma, received an infusion of its EB103 CD19-Redirected Artemis T cells after relapsing three times following prior treatments. "We are cautiously optimistic about these early results," it said. Shares edge lower in postmarket trading after ending Friday's regular session up 22% to $1.19.

Amazon.com will start stockpiling opioid overdose medication across its warehouse network, The Wall Street Journal reported. The move makes the retailer one of the largest U.S. employers to respond to government pressure to make life saving drugs available in the workplace. It plans to equip its North American facilities with the overdose reversal medication naloxone, sometimes known by the brand name Narcan.

Write to Connor Hart at connor.hart@wsj.com

(END) Dow Jones Newswires

September 27, 2024 18:58 ET (22:58 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.